Innate Pharma announces conference call and webcast for first half 2022 business update

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a conference call on Thursday, September 15, 2022, at 2 p.m. CEST / 8 a.m. EDT, to give an update on business progress during the first half of 2022.

Speakers during the call will be: 
•    Mondher Mahjoubi, Chief Executive Officer 
•    Joyson Karakunnel, Executive Vice President, Chief Medical Officer
•    Frédéric Lombard, Senior Vice President, Chief Financial Officer 
•    Yannis Morel, Executive Vice President, Product Portfolio Strategy & Business Development 

Details for the Virtual Event:

The live webcast will be available at the following link: 
https://event.on24.com/wcc/r/3824660/86089F900A17B3EA55F4BEE49AD268A8

Participants may also join via telephone to ask questions by registering in advance of the event at: https://registrations.events/direct/ID60133. Upon registration, participants will be provided with dial-in numbers, a direct event passcode and a unique registrant ID that they may use 10 minutes prior to the event start to access the call. Call reminders will also be sent to registered participants via e-mail the day prior to the event.

This information can also be found on the Investors section of the Innate Pharma website, www.innate-pharma.com. A replay of the webcast will be available on the Company website for 90 days following the event.